Healthcare Stocks

Peltz's Trian seeks to rally Disney shareholders against board director Froman

  • February 02, 2023 03:20 PM EST | Reuters
 Peltz's Trian seeks to rally Disney shareholders against board director Froman

(Adds Disney comments) By Svea Herbst-Bayliss NEW YORK, Feb 2 (Reuters) - Activist investor Nelson Peltz's hedge fund Trian Fund Management wrote to Walt Disney Co shareholders on Thursday to make the

Read More...
CANADA RESEARCH ROUNDUP-Canadian Pacific Railway, Pro REIT, Teck Resources

CANADA RESEARCH ROUNDUP-Canadian Pacific Railway, Pro REIT, Teck Resources

  • February 01, 2023 08:36 AM EST | Reuters

Feb 1 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including Canadian Pacific Railway, Pro REIT and Teck Resources, on Wednesday. HIGHLIGHTS *

Read More...
XORTX Announces Submission Of Orphan Drug Designation Request For XRx-008 Program

XORTX Announces Submission Of Orphan Drug Designation Request For XRx-008 Program

  • February 01, 2023 07:21 AM EST | Reuters

Feb 1 (Reuters) - XORTX Therapeutics Inc: * XORTX ANNOUNCES SUBMISSION OF ORPHAN DRUG DESIGNATION REQUEST FOR XRX-008 PROGRAM TO TREAT AUTOSOMAL DOMINANT KIDNEY DISEASE Source text for Eikon: Further

Read More...
Medicure Announces Resignation Of Board Member And Grant Of Stock Options

Medicure Announces Resignation Of Board Member And Grant Of Stock Options

  • February 01, 2023 07:17 AM EST | Reuters

Feb 1 (Reuters) - Medicure Inc: * MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS Source text for Eikon: Further company coverage:

Read More...
Numinus Receives Clinical Trial Application Approval From Health Canada

Numinus Receives Clinical Trial Application Approval From Health Canada

  • February 01, 2023 07:11 AM EST | Reuters

Feb 1 (Reuters) - Numinus Wellness Inc: * NUMINUS RECEIVES CLINICAL TRIAL APPLICATION APPROVAL FROM HEALTH CANADA FOR EXPERIENTIAL PSYCHEDELIC-ASSISTED THERAPY TRAINING USING PSILOCYBE CUBENSIS TEA

Read More...
PRESS DIGEST-Canada - Feb 1

PRESS DIGEST-Canada - Feb 1

  • February 01, 2023 06:53 AM EST | Reuters

Feb 1 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL - The Alberta

Read More...
PanGenomic Health Announces Intention To Dual List On The UK Aquis Stock Exchange Growth Market

PanGenomic Health Announces Intention To Dual List On The UK Aquis Stock Exchange Growth Market

  • January 31, 2023 09:15 AM EST | Reuters

Jan 31 (Reuters) - Pangenomic Health Inc: * PANGENOMIC HEALTH ANNOUNCES INTENTION TO DUAL LIST ON THE UK AQUIS STOCK EXCHANGE GROWTH MARKET Source text for Eikon: Further company coverage:

Read More...
CANADA RESEARCH ROUNDUP-BRP, Conifex Timber, Definity Financial

CANADA RESEARCH ROUNDUP-BRP, Conifex Timber, Definity Financial

  • January 30, 2023 10:59 AM EST | Reuters

Jan 30 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including BRP, Conifex Timber and Definity Financial, on Monday. HIGHLIGHTS * BRP Inc :

Read More...
Recruiting Underway In Fsd Pharma's Phase 2 Trial Of Fsd-Pea For Treatment Of Chronic Pain Associated With Idiopathic Mcas

Recruiting Underway In Fsd Pharma's Phase 2 Trial Of Fsd-Pea For Treatment Of Chronic Pain Associated With Idiopathic Mcas

  • January 30, 2023 08:59 AM EST | Reuters

Jan 30 (Reuters) - FSD Pharma Inc: * RECRUITING UNDERWAY IN FSD PHARMA’S PHASE 2 TRIAL OF FSD-PEA (FSD201) FOR THE TREATMENT OF CHRONIC PAIN ASSOCIATED WITH IDIOPATHIC MCAS (MCAD) Source text for

Read More...
Aleafia Health Signs A New European Cannabis Distribution Partner

Aleafia Health Signs A New European Cannabis Distribution Partner

  • January 30, 2023 07:47 AM EST | Reuters

Jan 30 (Reuters) - Aleafia Health Inc: * ALEAFIA HEALTH INC - SIGNED A NEW EUROPEAN CANNABIS DISTRIBUTION PARTNER, REPRESENTING A ONE-YEAR, APPROXIMATELY $1 MILLION CONTRACT Source text for Eikon:

Read More...
Sernova Announces Advancements With Its Novel Cell Pouch System

Sernova Announces Advancements With Its Novel Cell Pouch System

  • January 30, 2023 07:46 AM EST | Reuters

Jan 30 (Reuters) - Sernova Corp: * SERNOVA ANNOUNCES ADVANCEMENTS WITH ITS NOVEL CELL POUCH SYSTEM™ TO PRESERVE THYROID FUNCTION FOLLOWING TOTAL THYROIDECTOMY * SERNOVA CORP-STUDY DEMONSTRATES THYROID

Read More...

Frequently Asked Questions

There are multiple ways to look at any stock. It may include looking at fundamentals like dividends, earnings over the last few years, and ratios like price-to-earnings (P/E). The other way might be to look at what the future may hold. In the event of a large-scale demand in the future for a particular drug or vaccine that a company has produced or is likely to produce in the near term, the company's stock may find more backers. A look at what the company provides in the market, which can include hospital services, might be a good way to look at healthcare stocks.

There is a variety of choices available to the investor. Stocks represent companies that operate in sectors like healthcare, oil and gas, cannabis, and the list is long. The best stocks may relate to a particular industry, for example, the clean energy sector which has participants like Brookfield Renewable Partners, and Northland Power, or they can be a diversified mix of clean energy stocks and other sectors like oil and energy. In order to pick the best, the investor must study a little about the near-term market prospects for the related sector.

Considering the market environment at the time of writing this, Verde Agritech PLC (TSX: NPK) appears to be one of the fastest-growing stocks in Canada, with a price-to-earnings (P/E) ratio of 114.3. This crop nutrition and input stock has zoomed by over 450 per cent in the last 12 months. On the financial front, Verde Agritech expanded its 2021 net profit by 540 per cent year-on-year (YoY), and it expects 2022 revenue to reach C$ 72.26 million. However, investors should note that a stock’s performance can change depending on market conditions.

Healthcare stocks represent entities that provide arguably one of the most basic necessities to the wider world. They become even more crucial at the time of a pandemic or a large-scale disease outbreak in any particular region. Healthcare remains a growing sector as cures for all diseases have yet to be identified, and new ones like Covid-19 can crop up at any time. This makes healthcare stocks an interesting watch for a lot of investors.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK